Duncan J. Wardrop, Edward G. Bowen: Nitrenium Ion-Mediated Alkene Bis-Cyclofunctionalization: Total Synthesis of (−)-Swainsonine. In: Organic Letters. Band13, Nr.9, 2011, S.2376–2379, doi:10.1021/ol2006117.
F. P. Guengerich u. a.: Isolation and characterization of a l-pyrindine fungal alkaloid. In: JACS 95, 1973, S. 2055–2056, doi:10.1021/ja00787a080.
S. M. Colegate u. a.: A spectroscopic investigation of swainsonine: an α-mannosidase inhibitor isolated from Swainsona canescens. In: Aust. J. Chem. 32, 1979, S. 2257–2264, doi:10.1071/CH9792257.
nih.gov
ncbi.nlm.nih.gov
P. R. Dorling u. a.: Lysosomal storage in Swainsona spp. toxicosis: an induced mannosidosis. In: Neuropathol Appl Neurobiol 4, 1978, S. 285–295, PMID 703929.
A. A. Watson u. a.: Polyhydroxylated alkaloids - natural occurrence and therapeutic applications. In: Phytochemistry 56, 2001, S. 265–295, PMID 11243453.
K. Olden u. a.: The potential importance of swainsonine in therapy for cancers and immunology. In: Pharmacol Ther 50, 1991, S. 285–290, PMID 1754603.
J. Y. Sun u. a.: Inhibition of the growth of human gastric carcinoma in vivo and in vitro by swainsonine. In: Phytomedicine 14, 2007, S. 353–359, PMID 17097281.
P. E. Shaheen u. a.: Phase II study of the efficacy and safety of oral GD0039 in patients with locally advanced or metastatic renal cell carcinoma. In: Investigational New Drugs 23, 2005, S. 577–581, PMID 16034517.
D. H. Pritchard u. a.: Swainsonine toxicosis suppresses appetite and retards growth in weanling rats. In: Research in Veterinary Science 48, 1990, S. 228–230, PMID 2110378.
R. J. Molyneux und L. F. James: Loco intoxication: indolizidine alkaloids of spotted locoweed (Astragalus lentiginosus). In: Science 216, 1982, S. 190–191, PMID 6801763.
scbt.com
Swainsonine bei Santa Cruz Biotechnology, Inc., abgerufen am 8. Januar 2012.